logo

Biogen Inc. (BIIB)



Trade BIIB now with
  Date
  Headline
2/11/2021 8:09:33 AM Biogen Reports Expiration Date Results Of Its Cash Tender Offer
2/3/2021 7:05:27 AM Biogen Q4 GAAP EPS $2.32; Non-GAAP EPS $4.58
2/1/2021 7:34:57 AM Biogen Says FDA Approved New Intramuscular Injection Route Of Administration For PLEGRIDY
1/29/2021 7:43:08 AM Biogen And Eisai Announce FDA's 3-Month Extension Of Review Period For BLA For Aducanumab
1/8/2021 7:46:24 AM Biogen Says First Patient Treated In Global Clinical Study, RESPOND
12/21/2020 7:37:49 AM Biogen: EC Approves New Intramuscular Injection Route Of Administration For PLEGRIDY For Relapsing-Remitting MS
12/1/2020 7:47:51 AM William Blair Reiterates Biogen Inc. (BIIB) At Market Perform
11/27/2020 7:35:27 AM Biogen And Sage Therapeutics Execute Global Collaboration And License Agreement
11/9/2020 4:49:37 PM William Blair Reiterates Biogen Inc. (BIIB) At Market Perform